fig4

Mouse tumor susceptibility genes identify drug combinations for multiple myeloma

Figure 4. Drug combinations involving mTOR and HDAC inhibitors have a cooperative effect leading to MYC protein degradation. Small molecules targeting the G-quadruplex structure in the MYC promoter inhibit MYC transcription. HDAC: histone deacetylase; mTOR: mechanistic target of rapamycin

Journal of Cancer Metastasis and Treatment
ISSN 2454-2857 (Online) 2394-4722 (Print)

Portico

All published articles are preserved here permanently:

https://www.portico.org/publishers/oae/

Portico

All published articles are preserved here permanently:

https://www.portico.org/publishers/oae/